Loading icon
Press enter or spacebar to select a desired language.
Research
Press enter or spacebar to select a desired language.

PubMed COVID-19 Clinical Care

861 - 870 of 2253 results found

mRNA lipid nanoparticles induce immune tolerance to treat human diseases

Date
Tuesday, September 19, 2023 - 4:00 AM
Description
Rapid developments in the coronavirus disease 2019 (COVID-19) mRNA vaccine showcased the power of lipid nanoparticle (LNP) delivery systems in fighting infectious diseases. In addition, mRNA therapeutics are also in development for cancer